Siramesine
id:
siramesine-184-15715233
title:
Siramesine
text:
Siramesine is a sigma receptor agonist, selective for the σ2 subtype. In animal studies, siramesine has been shown to produce anxiolytic and antidepressant effects. It was developed by the pharmaceutical company H Lundbeck for the treatment of anxiety, although development was discontinued after clinical trials showed a lack of efficacy in humans. Siramesine has been shown to produce an enhanced antidepressant effect when co-administered with NMDA antagonists. It has also been used to study the
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Siramesine
date created:
2007-06-16T22:55:55Z
date modified:
2024-09-07T12:39:52Z
main entity:
{"identifier":"Q7529961","url":"https://www.wikidata.org/entity/Q7529961"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/f/ff/Siramesine1.svg","width":471,"height":426}
fields total:
13
integrity:
16